Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MDGL |
---|---|---|
09:32 ET | 839 | 216.1 |
09:38 ET | 300 | 213.87 |
09:39 ET | 5800 | 215.89 |
09:41 ET | 225 | 215.89 |
09:43 ET | 100 | 214.805 |
09:48 ET | 285 | 212.973 |
09:50 ET | 500 | 216.2399 |
09:52 ET | 500 | 214.225 |
09:56 ET | 335 | 214.87 |
10:01 ET | 100 | 214.995 |
10:03 ET | 203 | 215.33 |
10:06 ET | 100 | 215.245 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Madrigal Pharmaceuticals Inc | 4.6B | -8.4x | --- |
BridgeBio Pharma Inc | 4.6B | -9.6x | --- |
Biohaven Ltd | 4.8B | -5.5x | --- |
Avidity Biosciences Inc | 4.9B | -14.1x | --- |
Immunovant Inc | 4.1B | -14.9x | --- |
Crinetics Pharmaceuticals Inc | 4.0B | -13.4x | --- |
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH). The Company's product candidate, resmetirom, is a once-daily, oral, liver-directed thyroid hormone receptor-β (THR-β) agonist designed to target key underlying causes of NASH. NASH is a more advanced form of non-alcoholic fatty liver disease (NAFLD). The Company’s clinical development program includes MAESTRO-NASH, MAESTRO-NAFLD-1, and MAESTRO-NASH OUTCOMES.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.6B |
---|---|
Revenue (TTM) | $14.6M |
Shares Outstanding | 21.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.44 |
EPS | $-25.50 |
Book Value | $20.39 |
P/E Ratio | -8.4x |
Price/Sales (TTM) | 317.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,622.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.